Stock Research for DEPO


Featured Broker: Ally Invest

Get the due diligence for another stock.


DEPO Stock Chart & Research Data

The DEPO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DEPO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


DEPO Due diligence Resources & Stock Charts

The DEPO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DEPO Detailed Price Forecast - CNN Money CNN View DEPO Detailed Summary - Google Finance
Yahoo View DEPO Detailed Summary - Yahoo! Finance Zacks View DEPO Stock Research & Analysis -

Stock Analysis

TradeIdeas View DEPO Trends & Analysis - Trade-Ideas Barrons View DEPO Major Holders - Barrons
NASDAQ View DEPO Call Transcripts - NASDAQ Seeking View DEPO Breaking News & Analysis - Seeking Alpha
Spotlight View DEPO Annual Report - OTC Report View DEPO OTC Short Report -
TradeKing View DEPO Fundamentals - TradeKing Charts View DEPO SEC Filings - Bar Chart
WSJ View Historical Prices for DEPO - The WSJ Morningstar View Performance/Total Return for DEPO - Morningstar
MarketWatch View the Analyst Estimates for DEPO - MarketWatch CNBC View the Earnings History for DEPO - CNBC
StockMarketWatch View the DEPO Earnings - StockMarketWatch MacroAxis View DEPO Buy or Sell Recommendations - MacroAxis
Bullish View the DEPO Bullish Patterns - American Bulls Short Pains View DEPO Short Pain Metrics -

Social Media Mentions

StockTwits View DEPO Stock Mentions - StockTwits PennyStocks View DEPO Stock Mentions - PennyStockTweets
Twitter View DEPO Stock Mentions - Twitter Invest Hub View DEPO Investment Forum News - Investor Hub
Yahoo View DEPO Stock Mentions - Yahoo! Message Board Seeking Alpha View DEPO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for DEPO - Insider Cow View Insider Transactions for DEPO - Insider Cow
CNBC View DEPO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DEPO - OTC Markets
Yahoo View Insider Transactions for DEPO - Yahoo! Finance NASDAQ View Institutional Holdings for DEPO - NASDAQ

Stock Charts

FinViz View DEPO Stock Insight & Charts - StockCharts View DEPO Investment Charts -
BarChart View DEPO Stock Overview & Charts - BarChart Trading View View DEPO User Generated Charts - Trading View

Latest Financial News for DEPO

Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc.
Posted on Wednesday August 15, 2018

Assertio Therapeutics, Inc. (NASDAQ:ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that its corporate name change from “Depomed, Inc.” to “Assertio Therapeutics, Inc.” became effective at 11:59 p.m. ET yesterday, August 14, 2018. In connection with the name change, the Company’s common stock will begin trading under a new ticker symbol “ASRT” and a new CUSIP number, 04545L 107, at the opening of trading today, August 15, 2018. “Over the last several years, we have taken strategic actions to transition the Company to focus on our neurology, orphan and specialty medicines,” said Arthur Higgins, President and CEO of Assertio Therapeutics, Inc. “As we’ve transformed, it has become clear that the name Depomed no longer accurately reflects the business we’re in today or the future direction in which we’re headed.

See what the IHS Markit Score report has to say about Depomed Inc.
Posted on Saturday August 11, 2018

The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

Depomed: 2Q Earnings Snapshot
Posted on Wednesday August 08, 2018

The Newark, California-based company said it had a loss of 33 cents per share. Earnings, adjusted for non-recurring costs and stock option expense, were 19 cents per share. The results exceeded Wall Street ...

Depomed Announces Second-Quarter 2018 Financial Results
Posted on Wednesday August 08, 2018

--Raises Full-Year Earnings and Adjusted EBITDA Guidance Range and Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise--. --Confirms Regulatory Plan to File for FDA Approval of Cosyntropin ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.